The firm, called
, is based in Raleigh. Pritchard is its chief executive officer.
"BioTechnology Transfer fulfills a large, unmet need for outsourced product development and regulatory submission services in this area," said Pritchard, who was director of development for StemCo before launching the new venture. "Our comprehensive services enable biotech companies to determine concept feasibility, develop marketable products and build their business efficiently."
Bill Usrey, a former operations director of Apogee Medical, is the company's chief operating officer.